Evotec Investor Relations Material

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is focused on the identification of novel medicines that improve the lives of patients with significant unmet medical needs, principally in oncology, inflammation, metabolic disorders and rare diseases. In addition to the development of its own pipeline of small molecule drugs, Evotec also develops new drugs for its partners through discovery programs in high value areas such as immuno-oncology, neuroscience and inflammation.